0,997  0,001  Analeptic
0,996  0,001  Respiratory analeptic
0,938  0,005  Apoptosis agonist
0,912  0,002  Muscle relaxant
0,903  0,002  Anesthetic
0,867  0,005  Antineoplastic (breast cancer)
0,839  0,004  Cardiotonic
0,840  0,005  Antineoplastic (lung cancer)
0,822  0,005  Antineoplastic (ovarian cancer)
0,827  0,011  Transcription factor NF kappa B inhibitor
0,816  0,003  Cytotoxic
0,813  0,007  CYP2C9 substrate
0,812  0,014  Antiinflammatory
0,793  0,009  Teratogen
0,769  0,003  Skeletal muscle relaxant
0,769  0,007  Chemopreventive
0,767  0,012  CYP3A4 substrate
0,751  0,006  Prostate cancer treatment
0,749  0,005  NOS2 expression inhibitor
0,748  0,005  Antineoplastic (cervical cancer)
0,748  0,011  Embryotoxic
0,717  0,005  Antineoplastic (melanoma)
0,715  0,013  Antineoplastic (colorectal cancer)
0,690  0,005  Heart failure treatment
0,686  0,004  Diuretic
0,680  0,015  TNF expression inhibitor
0,670  0,012  Antihypercholesterolemic
0,642  0,008  Hepatic disorders treatment
0,635  0,003  Transcription factor STAT3 inhibitor
0,636  0,014  Cholesterol antagonist
0,622  0,007  Antineoplastic (glioma)
0,624  0,009  NOS3 expression inhibitor
0,616  0,004  Transcription factor STAT inhibitor
0,619  0,016  Carcinogenic
0,609  0,009  Nitric oxide antagonist
0,599  0,007  UGT1A1 substrate
0,603  0,022  Antineoplastic (colon cancer)
0,603  0,024  Antileukemic
0,587  0,008  Hypoxia-inducible factor 1 alpha inhibitor
0,589  0,012  Antineoplastic (pancreatic cancer)
0,580  0,014  Antipruritic, allergic
0,567  0,004  Contraceptive
0,567  0,004  Interleukin 6 antagonist
0,560  0,014  AR expression inhibitor
0,553  0,020  Immunosuppressant
0,525  0,007  Antineoplastic (liver cancer)
0,516  0,009  UGT2B4 substrate
0,507  0,001  Na+ K+ transporting ATPase inhibitor
0,503  0,004  Lipocortins synthesis antagonist
0,503  0,011  ICAM1 expression inhibitor
0,500  0,019  Proliferative diseases treatment
0,501  0,020  Cytostatic
0,476  0,008  Hepatoprotectant
0,477  0,014  UGT1A6 substrate
0,466  0,006  Sodium/bile acid cotransporter inhibitor
0,473  0,014  Vascular (periferal) disease treatment
0,469  0,025  Chemoprotective
0,466  0,025  Antiosteoporotic
0,472  0,032  Bone diseases treatment
0,443  0,008  UGT2B7 substrate
0,443  0,010  Abortion inducer
0,458  0,026  Apoptosis antagonist
0,433  0,010  UGT1A3 substrate
0,438  0,022  Antineoplastic (glioblastoma multiforme)
0,446  0,033  Antifungal
0,422  0,013  UGT1A4 substrate
0,477  0,069  Caspase 9 stimulant
0,460  0,053  Antibacterial
0,420  0,014  P-glycoprotein inhibitor
0,436  0,030  Antihypertensive
0,405  0,006  DNA polymerase I inhibitor
0,419  0,020  Antineoplastic (renal cancer)
0,398  0,004  Contraceptive female
0,396  0,003  Mineralocorticoid receptor antagonist
0,423  0,033  Lipoprotein disorders treatment
0,408  0,019  UDP-glucuronosyltransferase substrate
0,399  0,011  Prostate disorders treatment
0,423  0,038  CYP2C19 substrate
0,416  0,032  Antioxidant
0,416  0,040  CYP2D6 substrate
0,358  0,004  Postmenopausal disorders treatment
0,359  0,006  Cholesterol synthesis inhibitor
0,375  0,025  Antineoplastic (endocrine cancer)
0,356  0,015  Antipruritic, non-allergic
0,390  0,052  Antithrombotic
0,335  0,007  UGT2B9 substrate
0,327  0,005  Aromatase inhibitor
0,354  0,034  Hypolipemic
0,354  0,042  Sensitization
0,329  0,019  Prostatic (benign) hyperplasia treatment
0,356  0,050  Radioprotector
0,356  0,063  Immunostimulant
0,330  0,042  Interleukin antagonist
0,329  0,047  Antihypoxic
0,292  0,021  Hair growth stimulant
0,289  0,023  Antiacne
0,285  0,020  UGT2B15 substrate
0,265  0,004  Arachidonic acid antagonist
0,276  0,024  Interferon gamma antagonist
0,296  0,045  Mutagenic
0,312  0,063  CYP1A2 substrate
0,264  0,017  Antiviral (Hepatitis B)
0,251  0,008  Microtubule formation inhibitor
0,244  0,016  VEGF expression inhibitor
0,282  0,056  Angiogenesis stimulant
0,233  0,010  Androgen antagonist
0,296  0,081  Caspase 3 stimulant
0,259  0,047  Platelet adhesion inhibitor
0,231  0,019  UGT2B10 substrate
0,280  0,068  UGT1A9 substrate
0,215  0,004  Androgen agonist
0,269  0,066  Tumour necrosis factor alpha release inhibitor
0,212  0,015  Choleretic
0,226  0,032  Antiviral (Influenza A)
0,207  0,015  UGT2B1 substrate
0,193  0,005  Anabolic
0,281  0,094  Antineoplastic (brain cancer)
0,202  0,017  Sulfotransferase substrate
0,301  0,121  Atherosclerosis treatment
0,253  0,076  Antineoplastic (non-small cell lung cancer)
0,234  0,058  Anesthetic general
0,206  0,030  Antifungal enhancer
0,179  0,006  5-Alpha-reductase inhibitor
0,200  0,027  Antihyperlipoproteinemic
0,206  0,038  Melanin inhibitor
0,313  0,151  Cyclophilin D inhibitor
0,313  0,151  Antidiabetic
0,221  0,058  Neurotrophic factor enhancer
0,184  0,022  Growth stimulant
0,250  0,089  Renal disease treatment
0,212  0,054  Growth hormone agonist
0,199  0,043  Toxic, respiratory center
0,229  0,075  Antineoplastic (lymphoma)
0,234  0,082  Cardiovascular analeptic
0,159  0,008  Premenstrual syndrome treatment
0,155  0,005  Anticholelithogenic
0,193  0,044  Protein kinase stimulant
0,174  0,026  Antineoplastic antibiotic
0,161  0,016  Toll-Like receptor 4 antagonist
0,256  0,112  Interleukin 2 agonist
0,215  0,072  VCAM1 expression inhibitor
0,144  0,009  Glycine receptor antagonist
0,149  0,015  UGT2B11 substrate
0,169  0,036  Farnesoid X receptor antagonist
0,216  0,085  Free radical scavenger
0,193  0,065  Antiviral (Hepatitis)
0,183  0,054  Protein-tyrosine phosphatase inhibitor
0,166  0,039  Protein-tyrosine phosphatase 1B inhibitor
0,222  0,096  Antineoplastic (sarcoma)
0,185  0,059  Antirickettsial
0,175  0,051  Antineoplastic (squamous cell carcinoma)
0,219  0,095  DNA synthesis inhibitor
0,143  0,019  ABCA1 expression enhancer
0,182  0,058  Phospholipase C inhibitor
0,169  0,047  Carcinogenic, group 3
0,198  0,076  Antiviral (Influenza)
0,229  0,109  Cardioprotectant
0,216  0,097  Antipyretic
0,162  0,045  Adenylate cyclase stimulant
0,142  0,030  Antineoplastic alkaloid
0,123  0,012  Glycine receptor agonist
0,206  0,110  DNA damaging
0,100  0,005  Lipocortins synthesis agonist
0,098  0,006  RNA-directed RNA polymerase stimulant
0,120  0,030  SULT1E1 substrate
0,172  0,082  LDLR expression enhancer
0,154  0,066  Lipid peroxidase inhibitor
0,089  0,004  Progesterone agonist
0,143  0,059  Skin whitener
0,155  0,073  Urolithiasis treatment
0,130  0,050  Alcohol dehydrogenase substrate
0,200  0,121  Interleukin agonist
0,086  0,009  Acetyl-CoA transferase 2 inhibitor
0,141  0,069  Ca2+-transporting ATPase inhibitor
0,171  0,099  Psychostimulant
0,122  0,052  Estrogen antagonist
0,119  0,051  Expectorant
0,122  0,055  Photosensitizer
0,086  0,021  Estrogen agonist
0,071  0,006  Microtubule stabilization
0,095  0,030  CDC25A inhibitor
0,138  0,078  Pregnane X receptor agonist
0,145  0,086  Thrombolytic
0,178  0,119  Platelet antagonist
0,167  0,110  Antihypertriglyceridemic
0,078  0,024  Nitric oxide donor
0,064  0,010  Glucocorticoid antagonist
0,059  0,007  Glucose-6-phosphate dehydrogenase inhibitor
0,114  0,062  Skin irritative effect
0,126  0,076  Antihemorrhagic
0,103  0,055  Antineoplastic, alkylator
0,131  0,085  Antineoplastic (carcinoma)
0,060  0,014  Progesterone antagonist
0,107  0,062  HDL-cholesterol increasing
0,090  0,045  Antiprotozoal activity enhancer
0,092  0,048  Transcription factor NF kappa B stimulant
0,206  0,164  CTGF expression inhibitor
0,134  0,093  Antidiarrheal
0,149  0,111  Antihelmintic
0,107  0,069  Endometrios treatment
0,057  0,020  Opioid kappa receptor agonist
0,048  0,012  Cholesterol absorption inhibitor
0,061  0,030  Protein 50S ribosomal subunit inhibitor
0,098  0,068  Estrogen receptor beta antagonist
0,054  0,025  Aldosterone antagonist
0,154  0,128  Antiparasitic
0,076  0,051  Antibiotic
0,059  0,035  Postcoital contraceptive
0,063  0,040  Transcription factor AP-1 inhibitor
0,039  0,016  HMG CoA reductase inhibitor
0,031  0,009  5-Alpha-reductase 1 inhibitor
0,157  0,136  Antiprotozoal (Leishmania)
0,086  0,065  Contraceptive male
0,103  0,083  Cell adhesion inhibitor
0,099  0,079  Mucolytic
0,049  0,030  Potassium channel Kv1.3 blocker
0,140  0,124  Cardiodepressant
0,143  0,128  Antineoplastic (bone cancer)
0,036  0,021  Tubulin agonist
0,025  0,010  Corticosteroid-like
0,149  0,135  Antiulcerative
0,020  0,006  Vitamin D receptor agonist
0,021  0,013  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,040  0,034  Hypogonadism treatment
0,090  0,085  Hedgehog signaling inhibitor
0,086  0,083  Bile acid receptor antagonist
0,085  0,083  Glutathione S-transferase substrate
0,099  0,096  Interleukin 2 antagonist
0,109  0,107  Antiparkinsonian, tremor relieving
0,018  0,016  5-Alpha-reductase 2 inhibitor

